125 related articles for article (PubMed ID: 1741548)
21. Biochemical and pharmacological activities of SR 27417, a highly potent, long-acting platelet-activating factor receptor antagonist.
Herbert JM; Bernat A; Valette G; Gigo V; Lale A; LaPlace MC; Lespy L; Savi P; Maffrand JP; Le Fur G
J Pharmacol Exp Ther; 1991 Oct; 259(1):44-51. PubMed ID: 1656029
[TBL] [Abstract][Full Text] [Related]
22. Augmentation of tumor metastasis by platelet-activating factor.
Im SY; Ko HM; Kim JW; Lee HK; Ha TY; Lee HB; Oh SJ; Bai S; Chung KC; Lee YB; Kang HS; Chun SB
Cancer Res; 1996 Jun; 56(11):2662-5. PubMed ID: 8653713
[TBL] [Abstract][Full Text] [Related]
23. Effect of platelet activating factor antagonist WEB 2086 on the production of TNF from murine peritoneal macrophages.
Ju DW; Zheng QY; Wang HB; Wang XF; Fang J
Yao Xue Xue Bao; 1993; 28(10):721-7. PubMed ID: 8009983
[TBL] [Abstract][Full Text] [Related]
24. Platelet-activating factor and bacteremia-induced pulmonary hypertension.
Clavijo LC; Carter MB; Matheson PJ; Wills-Frank LA; Wilson MA; Wead WB; Garrison RN
J Surg Res; 2000 Feb; 88(2):173-80. PubMed ID: 10644485
[TBL] [Abstract][Full Text] [Related]
25. Role of nitric oxide and platelet-activating factor in cardiac alterations induced by tumor necrosis factor-alpha in the guinea-pig papillary muscle.
Alloatti G; Penna C; De Martino A; Montrucchio G; Camussi G
Cardiovasc Res; 1999 Mar; 41(3):611-9. PubMed ID: 10435033
[TBL] [Abstract][Full Text] [Related]
26. Effect of PAF receptor antagonism on cardiopulmonary alterations during coinfusion of TNF-alpha and IL-1 alpha in pigs.
Kruse-Elliott KT; Pino MV; Olson NC
Am J Physiol; 1993 Feb; 264(2 Pt 1):L175-82. PubMed ID: 8383447
[TBL] [Abstract][Full Text] [Related]
27. Platelet-activating factor mediates pulmonary macromolecular leak following intestinal ischemia-reperfusion.
Carter MB; Wilson MA; Wead WB; Garrison RN
J Surg Res; 1996 Feb; 60(2):403-8. PubMed ID: 8598677
[TBL] [Abstract][Full Text] [Related]
28. Intrapulmonary tumor necrosis factor triggers local platelet-activating factor production in rat immune complex alveolitis.
Warren JS; Barton PA; Mandel DM; Matrosic K
Lab Invest; 1990 Dec; 63(6):746-54. PubMed ID: 2255183
[TBL] [Abstract][Full Text] [Related]
29. Platelet-activating factor antagonists suppress the generation of tumor necrosis factor-alpha and superoxide induced by lipopolysaccharide or phorbol ester in rat liver macrophages.
Zhang F; Decker K
Eur Cytokine Netw; 1994; 5(3):311-7. PubMed ID: 7948767
[TBL] [Abstract][Full Text] [Related]
30. Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor.
Heuer HO; Casals-Stenzel J; Muacevic G; Weber KH
J Pharmacol Exp Ther; 1990 Dec; 255(3):962-8. PubMed ID: 2262914
[TBL] [Abstract][Full Text] [Related]
31. Platelet-activating factor is a mediator in tumor necrosis factor/galactosamine-induced lethality.
Libert C; Van Molle W; Brouckaert P; Fiers W
J Inflamm; 1995-1996; 46(3):139-43. PubMed ID: 8844494
[TBL] [Abstract][Full Text] [Related]
32. Effect of ADP-induced platelet aggregation on lung fluid balance in sheep.
Minnear FL; Moon DG; Kaplan JE; Malik AB
Am J Physiol; 1982 Apr; 242(4):H645-51. PubMed ID: 6802000
[TBL] [Abstract][Full Text] [Related]
33. Nitric oxide mediates angiogenesis induced in vivo by platelet-activating factor and tumor necrosis factor-alpha.
Montrucchio G; Lupia E; de Martino A; Battaglia E; Arese M; Tizzani A; Bussolino F; Camussi G
Am J Pathol; 1997 Aug; 151(2):557-63. PubMed ID: 9250168
[TBL] [Abstract][Full Text] [Related]
34. [Effects of the PAF antagonist WEB 2086 on hypoxia and angiotensin II-induced pulmonary vasoconstriction in the isolated perfused rat lung].
Kempfert C; Brandt R; Siewert B; Kanowski U; Oddoy A
Pneumologie; 1991 Oct; 45(10):799-803. PubMed ID: 1758848
[TBL] [Abstract][Full Text] [Related]
35. Platelet-activating factor and arachidonic acid metabolites mediate tumor necrosis factor and eicosanoid kinetics and cardiopulmonary dysfunction during bacteremic shock.
Quinn JV; Slotman GJ
Crit Care Med; 1999 Nov; 27(11):2485-94. PubMed ID: 10579269
[TBL] [Abstract][Full Text] [Related]
36. Mechanisms of the cardioprotective actions of WEB-2170, bepafant, a platelet activating factor antagonist, in myocardial ischemia and reperfusion.
Ma XL; Weyrich AS; Krantz S; Lefer AM
J Pharmacol Exp Ther; 1992 Mar; 260(3):1229-36. PubMed ID: 1545390
[TBL] [Abstract][Full Text] [Related]
37. Pharmacological activities of a novel thienodiazepine derivative as a platelet-activating factor antagonist.
Tsunoda H; Sakuma Y; Harada K; Muramoto K; Katayama S; Horie T; Shimomura N; Clark R; Miyazawa S; Okano K
Arzneimittelforschung; 1990 Nov; 40(11):1201-5. PubMed ID: 2085331
[TBL] [Abstract][Full Text] [Related]
38. PAF potentiates protamine-induced lung edema: role of pulmonary venoconstriction.
Chen CR; Voelkel NF; Chang SW
J Appl Physiol (1985); 1990 Mar; 68(3):1059-68. PubMed ID: 2341334
[TBL] [Abstract][Full Text] [Related]
39. Contribution of platelet activating factor to hemodynamic and sympathetic responses to bacterial endotoxin in conscious rats.
Qi M; Jones SB
Circ Shock; 1990 Oct; 32(2):153-63. PubMed ID: 2253318
[TBL] [Abstract][Full Text] [Related]
40. Platelet activating factor mediates interleukin-2-induced lung injury in the rat.
Rabinovici R; Sofronski MD; Renz JF; Hillegas LM; Esser KM; Vernick J; Feuerstein G
J Clin Invest; 1992 May; 89(5):1669-73. PubMed ID: 1314853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
